XML 377 R123.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation Restricted Stock Activity (Details) - $ / shares
12 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Stock units vested and undistributed   97,544
Restricted Stock Awards [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Number of Shares, Beginning Balance 6,291  
Number of Shares, Granted 1,820  
Number of Shares, Vested (6,907)  
Number of Shares, Forfeited 0  
Number of Shares, Ending Balance 1,204  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Weighted-Average Grant-Date Fair Value, Beginning Balance $ 268.64  
Weighted-Average Grant-Date Fair Value, Granted 372.50  
Weighted-Average Grant-Date Fair Value, Vested 277.90  
Weighted-Average Grant-Date Fair Value, Forfeited 0  
Weighted-Average Grant-Date Fair Value, Ending Balance $ 372.50  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 1,204  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 372.50  
Restricted Stock Units [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Number of Shares, Beginning Balance 622,564  
Number of Shares, Granted 332,430  
Number of Shares, Vested (260,216)  
Number of Shares, Forfeited (59,691)  
Number of Shares, Ending Balance 635,087  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Weighted-Average Grant-Date Fair Value, Beginning Balance $ 233.79  
Weighted-Average Grant-Date Fair Value, Granted 363.67  
Weighted-Average Grant-Date Fair Value, Vested 241.06  
Weighted-Average Grant-Date Fair Value, Forfeited 324.57  
Weighted-Average Grant-Date Fair Value, Ending Balance $ 290.26  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 489,507  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 324.11